ClinicalTrials.gg
Not yet recruitingNCT05232045Updated Oct 9, 2026

Automated System for Monitoring Urine Output in Intensive Care Patients

An observational study in Acute Kidney Injury in the ICU, sponsored by Meir Medical Center. Not yet recruiting at 1 site in Israel. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-10-09.

Sponsored by Meir Medical Center · Observational

How we know

Updated Oct 9, 2026Start date movedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
1,800
Ages
18 Years to 100 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Acute Kidney Injury with a site in Israel — 3 open to participants now, 4 under way, none of them phase 3. Acute Kidney Injury · Israel.

Started
2027
the only one that year
Observational
6 of 13
3 open now
Registered
9th of 13
by date
Lead sponsor
1 of 13
Meir Medical Center

Among the 13 studies in Acute Kidney Injury with a site in Israel, this one is the only one that started in 2027, is one of 6 observational ones, and was the 9th registered.

Acute Kidney Injury

1,693 studies on the registry are indexed under Acute Kidney Injury; 392 are open to participants now.

Browse Acute Kidney Injury studies →

Open to participants now

3 of the 13 studies in Acute Kidney Injury with a site in Israel are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Israel have not opened yet or have stopped. Only those recruiting at a site in Israel →

Who these studies take

Of the 229 Acute Kidney Injury studies recruiting now, 161 (70%) set no upper age limit and 35 (15%) stop at 75 or younger; 22 take children under 18; 25 take healthy volunteers.

This study: 18 Years to 100 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Acute Kidney Injury with a site in Israel, or all of them as a file.
02

Study summary

Acute kidney injury is common among ICU-admitted patients, and is associated with increased morbidity and mortality. Early recognition is essential to prevent complications. In this study we aim to examine whether strict monitoring of urine output may reduce the incidence of acute kidney injury, allow for less positive fluid balance and reduce the clinical symptoms of fluid overload in ICU patients. Currently we monitor urine output using a Urinometer, with manual recording. From June 2022 we will begin routine use of an automated urine monitoring system in the ICU and test its effect on the parameters listed above. We will conduct a before-after retrospective intervention. The group of patients in whom the automated system will be used, from June 2022 to January 2024, will be the study group. The patients admitted to the ICU in the period between January 2021 and June 2022 will be the control group. We will include patients aged 18-100, who were admitted to the General Intensive Care Unit in Meir Medical Center from January 2021 to January 2024, and had admission time longer than 48 hours. Patients without a urinary catheter will not be included. The study will be conducted in the format of observational data collection from hospital files and computerized systems (Metavision system and Chameleon system). We estimate that we will include about 900 patients in the study group and about 900 in the control group. All demographic and inpatient data will be statistically examined by a qualified statistician depending on the type of data.

03

Conditions studied

  • Acute Kidney Injury in the ICU

Browse trials for

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients aged 18-100, who were admitted to the General Intensive Care Unit in Meir Medical Center from January 2021 to January 2024

Eligibility criteria

Inclusion Criteria: Patients aged 18-100, who were admitted to the General Intensive Care Unit in Meir Medical Center from January 2021 to January 2024, and had admission times longer than 48 hours.

-

Exclusion Criteria: Patients without a urinary catheter, Patients with admission times less than 48 hours.

-

05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
1,800 participants (estimated)
Patient registry
No

Groups and cohorts

  • Automated urinary output collection system group (tight monitoring of urine output)

    Drug: Automated urinary output collection system group (tight monitoring of urine output)

  • Manual urinary output collection system group (routine monitoring of urine output)

Interventions

  • DrugAutomated urinary output collection system group (tight monitoring of urine output)

    Automated urinary output collection system group (tight monitoring of urine output)

06

What researchers measure

Primary outcomes

  1. Prevalence of acute kidney injury

    Primary outcome: To investigate whether the use of an automatic urinary output monitoring system in ICU patients will decrease the incidence of acute kidney injury

    Time frame: June 2023-January 2024

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Start is estimated for Dec 2027; primary completion for Jan 2029, 13 months later.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 9, 2026: start Dec 2025 → Dec 2027, primary completion Jan 2026 → Jan 2029 and completion Jun 2026 → Jun 2029.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 1, 2022
First posted
Feb 9, 2022
StartEst.
Dec 1, 2027was Dec 2025
Primary completionEst.
Jan 1, 2029was Jan 2026
CompletionEst.
Jun 1, 2029was Jun 2026
Last update
Oct 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Dec 2025→Dec 1, 2027
Oct 9, 2026
Primary completion
Jan 2026→Jan 1, 2029
Oct 9, 2026
Study completion
Jun 2026→Jun 1, 2029
Oct 9, 2026
Show all 1 update
  1. Oct 9, 2026
    Start date Dec 2025→Dec 1, 2027
    Primary completion Jan 2026→Jan 1, 2029
    Study completion Jun 2026→Jun 1, 2029
    + 3 other changes: index terms, verification date and criteria formatting

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05232045
Responsible party
sara dichtwald (Dr, Meir Medical Center) — Principal investigator
First posted
Feb 9, 2022
Start date
Dec 1, 2027 (estimated)
Primary completion
Jan 1, 2029 (estimated)
Completion
Jun 1, 2029 (estimated)
Last update
Oct 9, 2026

Study contacts

Sara Dichtwald, Dr
Contact
sara.dichtwald@clalit.org.il
972-9-7472133 ext. 1

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion